Back to Stakeholders

Nevada's Medicaid authority publishing pharmacy and physician-administered drug policy materials used for access and prior-authorization decisions, including Spravato-related references in archived DUR and update documents.

Reimbursement & Market Access Snapshot

Insurance Payers & Reimbursement Specialists

Service Model

Public Payer / National Coverage Authority

Jurisdiction

Subnational / State-Level

Coverage

1 country

Last Verified

Apr 11, 2026

Focus Areas

Coverage Policy DesignFormulary & Access CriteriaPayment Coding Pathways

Evidence Requirements

Clinical Efficacy EndpointsComparative Effectiveness

Market Access Notes

Nevada Medicaid resources indicate Spravato-related review and preferred list update activity in payer policy workflows.

Verification

Verified

Psychedelic Focus

Psychedelic-Adjacent Focus

Engagement Status

Active

Verification Notes

Verified using Nevada Medicaid archive/update pages that explicitly reference Spravato (esketamine).

Primary Access Link

Quick Facts

Website
Visit